Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 229

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus

Lee, Pui Y., Li, Yi, Richards, Hanno B., Chan, Fay S., Zhuang, Haoyang, Narain, Sonali, Butfiloski, Edward J., Sobel, Eric S., Reeves, Westley H., Segal, Mark S.·2007·Arthritis & Rheumatism

Abstract

Objective: The premature atherosclerosis seen in patients with systemic lupus erythematosus (SLE) is not explained by traditional risk factors. SLE disease activity, such as renal involvement and presence of autoantibodies, is associated with elevated serum levels of type I interferon (IFN‐I), a family of cytokines with potent antiviral and antiproliferative effects. This study was undertaken to test the hypothesis that elevated IFN‐I levels could lead to endothelial dysfunction, a surrogate for cardiovascular disease, by causing a reduction in the number of endothelial progenitor cells (EPCs), bone marrow–derived cells that participate in endothelial repair. Methods: EPCs were enumerated in the peripheral blood of SLE patients (n = 70) and healthy controls (n = 31), using a colony‐forming assay. Serum IFN‐I levels were quantified by real‐time polymerase chain reaction measurement of the expression of the IFN‐I–inducible gene MX1. Endothelial function was determined by peripheral arterial plethysmography. Results: SLE patients had markedly reduced levels of EPC colony‐forming units compared with controls (median 5.7/ml peripheral blood [interquartile range 1.9–12.8] versus 28.5/ml peripheral blood [14.7–47.3]; P < 0.0001), and the depletion of EPCs was more dramatic in patients with elevated levels of IFN‐I. Stepwise multiple regression analysis showed that MX1 expression and serum levels of C‐reactive protein were independently associated with the reduction of EPCs. Importantly, high IFN‐I levels were associated with impaired endothelial function in patients with SLE. Conclusion: These data support the novel hypothesis that depletion of EPCs caused by excessive IFN‐I may be linked to endothelial dysfunction and increased cardiovascular risk in SLE.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1002/art.23035

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 229

Metadata

Authors
Lee, P. Y., Li, Y., Richards, H. B., Chan, F. S., Zhuang, H., Narain, S., Butfiloski, E. J., Sobel, E. S., Reeves, W. H., & Segal, M. S.
Venue
Arthritis & Rheumatism
Publisher
Wiley
Published
2007-10-29
Volume
56
Issue
11
Pages
3759-3769
ISSN
  • 0004-3591 (ISSN-L)
  • 1529-0131
OpenAlex
W2004181624
Cited by
229
References
3
FWCI
10.55
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus. https://app.cochat.ai/papers/10.1002/art.23035
The paper
Lee, P. Y., Li, Y., Richards, H. B., Chan, F. S., Zhuang, H., Narain, S., Butfiloski, E. J., Sobel, E. S., Reeves, W. H., & Segal, M. S. (2007). Type I interferon as a novel risk factor for endothelial progenitor cell depletion and endothelial dysfunction in systemic lupus erythematosus. Arthritis & Rheumatism. https://doi.org/10.1002/art.23035

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.